Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Celgene’s triple multiple myeloma therapy clears phase III trial

Celgene’s triple multiple myeloma therapy clears phase III trial biggest-selling drug Revlimid as a maintence treatment for multiple myeloma patients. ... The trial is the only phase III study to date investigating a triple combination in patients who have all received prior therapy - Revlimid - and according to the

Celgene reaches $9bn agreement to buy Juno

Celgene reaches $9bn agreement to buy Juno Celgene is already a big player in blood cancers and haematology with Revlimid (lenalidomide), Pomalyst (pomalidomide) and Thalomid (thalidomide), and buying Juno keeps it in the running for a new generation ... of cell-based therapies in these areas at

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF Last year, NICE said it was unable to make a recommendation about use of Darzalex in combination with Celgene’s Revlimid (lenalidomide) and dexamethasone for relapsed and refractory myeloma because Janssen

Is acquisitive Celgene now eyeing CAR-T specialist Juno?

Is acquisitive Celgene now eyeing CAR-T specialist Juno? Buying Juno could make a lot of sense for Celgene, which is already a big player in blood cancers and could potentially pair its drug-based therapies such as blockbuster Revlimid

Progression-free Living

This, combined with loss of CDF funding for REVLIMID (lenalidomide) as a second line treatment posed a significant challenge to maintaining market share. ... REVLIMID can provide this. To address these challenges, Celgene fundamentally overhauled its data

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics